Stocks and Investing Stocks and Investing
Thu, April 30, 2020

Jailendra Singh Maintained (TDOC) at Hold with Increased Target to $165 on, Apr 30th, 2020


Published on 2024-10-27 04:40:05 - WOPRAI, Jailendra Singh
  Print publication without navigation


Jailendra Singh of Credit Suisse, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Increased Target from $152 to $165 on, Apr 30th, 2020.

Jailendra has made no other calls on TDOC in the last 4 months.



There are 12 other peers that have a rating on TDOC. Out of the 12 peers that are also analyzing TDOC, 7 agree with Jailendra's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jamie Stockton of "Wells Fargo" Maintained at Hold with Increased Target to $135 on, Thursday, April 16th, 2020
  • Matthew Gillmor of "Baird" Maintained at Hold with Increased Target to $135 on, Wednesday, April 15th, 2020
  • Steven Halper of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $145 on, Wednesday, April 15th, 2020
  • Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold on, Tuesday, March 31st, 2020
  • Sandy Draper of "SunTrust Robinson Humphrey" Maintained at Hold with Increased Target to $118 on, Thursday, March 26th, 2020
  • Allen Lutz of "B of A Securities" Reiterated at Hold with Increased Target to $140 on, Thursday, February 27th, 2020
  • Steve Valiquette of "Barclays" Maintained at Hold with Increased Target to $95 on, Tuesday, January 14th, 2020


These are the ratings of the 5 analyists that currently disagree with Jailendra


  • Lisa Gill of "JP Morgan" Maintained at Buy with Increased Target to $182 on, Wednesday, April 15th, 2020
  • Charles Rhyee of "Cowen & Co." Maintained at Buy with Increased Target to $175 on, Wednesday, April 15th, 2020
  • George Hill of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $172 on, Wednesday, April 15th, 2020
  • Sean Wieland of "Piper Sandler" Maintained at Buy with Increased Target to $193 on, Wednesday, April 15th, 2020
  • Sean Dodge of "RBC Capital" Maintained at Buy with Increased Target to $110 on, Tuesday, January 21st, 2020
Contributing Sources